Results 71 to 80 of about 29,168 (237)

Controlling Growth of Ultrasmall Sub‐10 nm Silver Nanoparticles From Cotinus coggygria Scop. Extract and Evaluation of Its In Vitro Anti‐Breast Cancer, Antioxidant and Antimicrobial Activity

Journal of Applied Toxicology, EarlyView.
ABSTRACT This study highlights the potential use of Cotinus coggygria Scop. plant extract in a single‐step synthesis of biocompatible and ultrasmall AgNPs for in vitro applications. Herein, microscopic analyses revealed that AgNP exposure did not induce appreciable morphological changes in CRL‐4010 cells, whereas MCF‐7 and MDA‐MB‐231 cells exhibited ...
Ümran Ünüvar, Tuğba Nur Aslan, Suray Pehlivanoğlu, Kübra Ece Coşkuner   +3 more
wiley   +1 more source

Flavouring Group Evaluation 413 (FGE.413): Naringenin [PDF]

The EFSA Panel on Food Additives and Flavourings (FAF) was requested to evaluate the safety of naringenin [FL‐no: 16.132] as a new flavouring substance, in accordance with Regulation (EC) No 1331/2008.
Cordelli, Eugenia, Agnieszka Mech, MAnco, Melania, Bolognesi, Claudia, Nørby, Karin, Claudia Bolognesi, Maria Carfí, Maged Younes, Peter Moldeus, Sabina Passamonti, Multari, Salvatore, Mennes, Wim, Chipman, Kevin, Gabriele Aquilina, Rainer Gürtler, Romina Shah, Degen, Gisela, Younes, Maged, Shah, Romina, Gisela Degen, Melania Manco, Matthew Wright, Aquilina, Gabriele, Eugenia Cordelli, Laurence Castle, Romualdo Benigni, Karl‐Heinz Engel, Gagliardi, Gabriele, Ursula Gundert‐Remy, Benigni, Romualdo, Ine Waalkens‐Berendsen, Frutos Fernandez, Maria José, CAstle, Laurenca, Gürtler, Rainer, Gabriele Gagliardi, Karin Nørby, Peter Fürst, EFSA Panel on Food Additives and Flavourings (FAF), Engel, Karl-Heinz, Camilla Svendsen, Salvatore Multari, Trine Husøy, Gundert-Remy, Ursula, Borana Dino, Borana, Dino, Fowler, Paul J., Passamonti, Sabina, Kevin Chipman, Wright, Matthew, Husøy, Trine, Paul J. Fowler, Moldeus, Peter, Maria José Frutos Fernandez, Waalkens-Berendsen, Ina, Svendsen, Camilla, Mech, Agnieszka, Wim Mennes, Carfí, Maria, Fürst, Peter   +58 more
core   +2 more sources

the case of naringenin

, 2022
Τα φυσικά προϊόντα (NPs) διαδραματίζουν βασικό ρόλο στη διαδικασία ανακάλυψης φαρμάκων, εξαιτίας της μεγάλης ποικιλομορφίας τους στη φύση, γεγονός που επιτρέπει τον εντοπισμό μορίων ενδιαφέροντος για την ανάπτυξη νέων θεραπευτικών παραγόντων.
Στύλος, Ευγένιος
core   +1 more source

Bisphenol A and Its Analogs: Toxicity Analysis in Mouse and Rat Liver—A Review

Journal of Applied Toxicology, EarlyView.
ABSTRACT Bisphenol A (BPA) and its analogs are widely recognized for their use in industry and plastic manufacturing. Consequently, humans and animals are continually exposed to various substances in their daily lives. This review evaluates the hepatic toxicity of BPA and its analogs in mice and rats, with particular emphasis on molecular mechanisms ...
Sevda Bagdatli, Muhammed Canik, Gizem Gencay, Nurbanu Zengin, Tarık Dinc, Nazan Deniz Yön   +5 more
wiley   +1 more source

Effects of catechins, resveratrol, silymarin components and some of their conjugates on xanthine oxidase‐catalyzed xanthine and 6‐mercaptopurine oxidation

Journal of the Science of Food and Agriculture, Volume 105, Issue 5, Page 2765-2776, 30 March 2025.
Abstract BACKGROUND Over the past two decades, the global incidence of gout has markedly increased, affecting people worldwide. Considering the side effects of xanthine oxidase (XO) inhibitor drugs (e.g. allopurinol and febuxostat) used in the treatment of hyperuricemia and gout, the potential application of phytochemicals has been widely studied.
Tímea Bencsik, Orsolya Balázs, Róbert G Vida, Balázs Z Zsidó, Csaba Hetényi, Kateřina Valentová, Miklós Poór   +6 more
wiley   +1 more source

From nature to nanoscale: advances, challenges, and preclinical translation of nanofiber drug delivery systems containing plant‐derived active ingredients

Journal of the Science of Food and Agriculture, EarlyView.
Abstract Since the early 1960s, nanotechnology has been a critical area of science, allowing for the development of sophisticated nanomaterials. Nanofibers, one of the most widely used nanotechnological drug delivery systems, have emerged as a highly versatile platform within modern pharmaceutical sciences.
Heybet Kerem Polat, Yasin Turanlı, Nihat Kurt, Sefa Gözcü, Emre Tunçel, Hilal Bacanak, Eren Aytekin, Sedat Ünal   +7 more
wiley   +1 more source

Antinociceptive and anti-inflammatory effects of the citrus flavanone naringenin

, 2019
Objective: Naringenin, a flavonoid found in citrus fruits, has notably diverse pharmacological properties. In the present study, we investigated the antinociceptive and anti-inflammatory effects of naringenin.
Chi-Chien Lin, Sen-Wei Tsai, Ting-Wen Chung, Shiming Li   +3 more
core   +1 more source

Bioactive Natural Products in Cardiovascular Disease: Focus on Thrombotic Events

Phytotherapy Research, EarlyView.
An overview of the role of natural products (NP) in cardiovascular disease prevention, highlighting key mechanisms of action: including antiplatelet, antithrombotic, anti‐inflammatory, and antioxidant effects. Additionally, it illustrates the integration of diet–drug interactions, nutritional epigenetics, and the role of artificial intelligence in ...
Maria Nektaria Magkoulia, Despoina Pantazi   +1 more
wiley   +1 more source

FORMULASI NANOPARTIKEL NARINGENIN UNTUK MEMPERBAIKI KARAKTERISTIK FISIKAKIMIA NARINGENIN SEBAGAI AGEN KEMOPREVENTIF SECARA IN VITRO DAN IN VIVO

, 2015
Info lebih lanjut hub: Lembaga Penelitian Universitas Jember Jl. Kalimantan No.37 Telp. 0331-339385 Fax. 0331-337818 JemberNaringenin merupakan agen kemopreventif yang potensial, namun karena kelarutannya yang rendah menyebabkan absorbsinya ke dalam ...
Lina Winarti, Lusia Oktora Ruma, K.S
core  

Multitarget Regulatory Mechanisms and Research Advances of Plant‐Derived Bioactive Ingredients in Hypertension Prevention and Management

Phytotherapy Research, EarlyView.
Schematic overview of the multi‐target and multi‐pathway mechanisms of PDBI in the prevention and management of hypertension. ABSTRACT Hypertension remains a major global risk factor for cardiovascular diseases, yet current treatments face challenges such as suboptimal blood pressure control and inadequate organ protection.
Qiqi Deng, Yonglin Zhang, Jing Pan, Jing Luo, Hualin Sun, Chaonian Li, Li Li   +6 more
wiley   +1 more source